What is the NOAEL for Enzacamene?
Enzacamene has 100 NOAEL studies in the database. The lowest reported value is 1 mg/kg bw/day via oral. Source: UnifiedCodex:SCCS_SHADOW:beta.noael_studies.
Also known as: Bicyclo[2.2.1]heptan-2-one, 1,7,7-trimethyl-3-[(4-methylphenyl)methylene]-, Eusolex 6300, Neo Heliopan MBC, 3-(p-Methylbenzylidene)camphor, 3-(p-Methylbenzylidene)-DL-camphor (+13 more)
CAS 36861-47-9
Enzacamene (CAS 36861-47-9) is a chemical substance. Key regulatory status: 4 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS.
View cosmetic safety profile for Enzacamene (4-Methylbenzylidene Camphor) →
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| consumer_product | P&G | Proctor & Gamble |
| IFRA Transparency | IFRA | IFRA |
| Canada; consumer_product; Substances in Products - Canada (4/2014) | Government of Canada | CPCat |
| Canada; pharmaceutical | DrugBank | DrugBank |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 1 | - | - | oral | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 4 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 25 | - | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 25 | mg/kg | - | dermal | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 25 | mg/kg bw/day | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 25 | mg/kg bw/day | - | oral | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 25 | mg/kg bw/day | - | oral | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| =30 | mg/kg bw/day | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 66 | mg/kg bw/day | - | dermal | human | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 100 | mg/kg/day | - | dermal | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 100 | mg/kg/day | - | dermal | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 100 | mg/kg/day | - | dermal | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 100 | mg/kg/day | - | dermal | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 100 | mg/kg bw/day | - | oral | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| =400 | - | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| =400 | - | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 400 | mg/kg/day | - | dermal | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 400 | mg/kg/day | - | dermal | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 400 | mg/kg bw /day | - | oral | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 2000 | mg/kg bw/day | - | - | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 8I3XWY40L9 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 8I3XWY40L9 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 8I3XWY40L9 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| =1 | - | NOAEL | oral | - | SCCS_vision_codex |
| =1 | - | NOAEL | oral | - | SCCS_vision_codex |
| =1 | - | NOAEL | oral | - | SCCS_vision_codex |
| =1 | - | NOAEL | oral | - | SCCS_vision_codex |
| =4 | - | NOAEL | - | - | SCCS_vision_codex |
| =4 | - | NOAEL | - | - | SCCS_vision_codex |
| =4 | - | NOAEL | - | - | SCCS_vision_codex |
| =4 | - | NOAEL | - | - | SCCS_vision_codex |
| =10 | mg/kg bw/day | NOAEL | - | - | SCCS_vision_codex |
| =10 | mg/kg bw/day | NOAEL | - | - | SCCS_vision_codex |
| =10 | mg/kg bw/day | NOAEL | - | - | SCCS_vision_codex |
| =10 | mg/kg bw/day | NOAEL | - | - | SCCS_vision_codex |
| =25 | - | NOAEL | oral | rat | SCCS_vision_codex |
| =25 | mg/kg/day | NOAEL | oral | rat | SCCS_vision_codex |
| =25 | mg/kg bw/day | NOAEL | dermal | - | SCCS_vision_codex |
| =25 | mg/kg | NOAEL | dermal | rat | SCCS_vision_codex |
| =25 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =25 | - | NOAEL | oral | rat | SCCS_vision_codex |
| =25 | mg/kg/day | NOAEL | oral | rat | SCCS_vision_codex |
| =25 | mg/kg bw/day | NOAEL | dermal | - | SCCS_vision_codex |
| =25 | mg/kg | NOAEL | dermal | rat | SCCS_vision_codex |
| =25 | - | NOAEL | oral | rat | SCCS_vision_codex |
| =25 | mg/kg/day | NOAEL | oral | rat | SCCS_vision_codex |
| =25 | mg/kg bw/day | NOAEL | dermal | - | SCCS_vision_codex |
| =25 | mg/kg | NOAEL | dermal | rat | SCCS_vision_codex |
| =25 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =25 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
Showing 50 of 100 studies
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Enzacamene has 100 NOAEL studies in the database. The lowest reported value is 1 mg/kg bw/day via oral. Source: UnifiedCodex:SCCS_SHADOW:beta.noael_studies.
Enzacamene appears on 4 regulatory/inventory lists including consumer_product, IFRA Transparency, Canada; consumer_product; Substances in Products - Canada (4/2014), and 1 more. Source: EPA CPDat.
Yes, Enzacamene is also indexed as a cosmetic ingredient under the name Enzacamene (4-Methylbenzylidene Camphor). View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Enzacamene also appears in cosmetics, pharmaceutical databases.